Aravind Ramakrishnan

2.6k total citations
56 papers, 1.1k citations indexed

About

Aravind Ramakrishnan is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Aravind Ramakrishnan has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 21 papers in Hematology and 18 papers in Molecular Biology. Recurrent topics in Aravind Ramakrishnan's work include CAR-T cell therapy research (18 papers), Acute Myeloid Leukemia Research (12 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Aravind Ramakrishnan is often cited by papers focused on CAR-T cell therapy research (18 papers), Acute Myeloid Leukemia Research (12 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Aravind Ramakrishnan collaborates with scholars based in United States, Japan and United Kingdom. Aravind Ramakrishnan's co-authors include Brian Hayes, H. Joachim Deeg, Robert K. Bradley, Ahmad S. Zebari, Janine O. Ilagan, Philip Bradley, Beverly Torok‐Storb, Manoj M. Pillai, Bart L. Scott and Barry E. Storer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Aravind Ramakrishnan

49 papers receiving 1.1k citations

Peers

Aravind Ramakrishnan
Jin Shao United States
Kentaro Minagawa Japan
Lalita Limaye India
Miki Yamaguchi Japan
Kenneth Langlands United Kingdom
Dora Višnjić Croatia
Kashish Chetal United States
Xiaoyong Chen China
Nicola H. Dryden United Kingdom
Peggy Kirstetter France
Jin Shao United States
Aravind Ramakrishnan
Citations per year, relative to Aravind Ramakrishnan Aravind Ramakrishnan (= 1×) peers Jin Shao

Countries citing papers authored by Aravind Ramakrishnan

Since Specialization
Citations

This map shows the geographic impact of Aravind Ramakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aravind Ramakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aravind Ramakrishnan more than expected).

Fields of papers citing papers by Aravind Ramakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aravind Ramakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aravind Ramakrishnan. The network helps show where Aravind Ramakrishnan may publish in the future.

Co-authorship network of co-authors of Aravind Ramakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Aravind Ramakrishnan. A scholar is included among the top collaborators of Aravind Ramakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aravind Ramakrishnan. Aravind Ramakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Casey, Betsy Blunk, Sarah T. Garber, et al.. (2025). Remote Patient Monitoring for 15 Vs. 30 Days in Outpatient Chimeric Antigen Receptor T-Cell Therapy (CAR-T) across a Large Health System. Transplantation and Cellular Therapy. 31(2). S223–S224.
2.
Dholaria, Bhagirathbhai, Mehmet H. Kocoglu, Leyla Shune, et al.. (2025). A Phase 1 Study of P-BCMA-ALLO1, a Non-Viral, Allogeneic BCMA Directed CAR-T in Relapsed/Refractory Multiple Myeloma (RRMM): Results from Optimized Lymphodepletion Cohort (Arm C). Transplantation and Cellular Therapy. 31(2). S38–S38.
3.
Majhail, Navneet S., Minoo Battiwalla, Aravind Ramakrishnan, et al.. (2025). Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring. JCO Oncology Practice. 21(11). 1601–1608. 1 indexed citations
4.
5.
Martin, Casey, Betsy Blunk, Aravind Ramakrishnan, et al.. (2024). Comparison of 15- Vs. 30-Day Remote Patient Monitoring for Outpatient Chimeric Antigen Receptor T-Cell Therapy (CAR-T) across a Large Health System. Blood. 144(Supplement 1). 2300–2300. 1 indexed citations
6.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2024). Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network. Blood Advances. 9(2). 429–435. 4 indexed citations
7.
8.
Battiwalla, Minoo, José C. Cruz, William B. Donnellan, et al.. (2024). Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting. PubMed. 6(4). 43–52. 1 indexed citations
9.
10.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2023). Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network. Transplantation and Cellular Therapy. 29(2). S55–S55. 2 indexed citations
11.
Cutler, Corey, Stephanie J. Lee, Sally Arai, et al.. (2021). Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213). Transplantation and Cellular Therapy. 27(3). S7–S8. 3 indexed citations
12.
Ramakrishnan, Aravind, Ann E. Woolfrey, Jan Hillson, et al.. (2021). Alpn-101 (ICOSL vIgD-Fc), a Dual Antagonist of the ICOS and CD28 Costimulatory Pathways, for Treatment of Steroid Refractory Acute GVHD (aGVHD): Case Report. Transplantation and Cellular Therapy. 27(3). S265–S266.
13.
14.
Ramakrishnan, Aravind. (2020). Phase 1 Alexander Study of AUTO3, the First CD19/22 Dual Targeting CAR T Cell Therapy, with Pembrolizumab in Patients with Relapsed/Refractory (r/r) DLBCL. 5 indexed citations
15.
Hayes, Brian, Kiet T. Phong, Meredith A. Redd, et al.. (2018). Engineering a multicellular vascular niche to model hematopoietic cell trafficking. Stem Cell Research & Therapy. 9(1). 77–77. 30 indexed citations
16.
Ilagan, Janine O., Aravind Ramakrishnan, Brian Hayes, et al.. (2014). U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Research. 25(1). 14–26. 210 indexed citations
17.
Yeung, Cecilia C.S., John Byon, Aravind Ramakrishnan, et al.. (2014). The KDM2B- Let-7b -EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy. PLoS ONE. 9(9). e107817–e107817. 23 indexed citations
18.
Iwata, Mineo, David K. Madtes, Kraig Abrams, et al.. (2013). Late Infusion of Cloned Marrow Fibroblasts Stimulates Endogenous Recovery from Radiation-Induced Lung Injury. PLoS ONE. 8(3). e57179–e57179. 2 indexed citations
19.
Trobridge, Grant D., Xiao‐Bing Zhang, Korashon L. Watts, et al.. (2010). Efficient Generation of Nonhuman Primate Induced Pluripotent Stem Cells. Stem Cells and Development. 20(5). 795–807. 23 indexed citations
20.
Harn, Chee Hark, Mary Beth Knight, Aravind Ramakrishnan, et al.. (1998). Isolation and characterization of the zSSIIa and zSSIIb starch synthase cDNA clones from maize endosperm. Plant Molecular Biology. 37(4). 639–649. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin Shao Breakdown of academic impact, for papers by Kentaro Minagawa Breakdown of academic impact, for papers by Lalita Limaye Breakdown of academic impact, for papers by Miki Yamaguchi Breakdown of academic impact, for papers by Kenneth Langlands Breakdown of academic impact, for papers by Dora Višnjić Breakdown of academic impact, for papers by Kashish Chetal Breakdown of academic impact, for papers by Xiaoyong Chen Breakdown of academic impact, for papers by Nicola H. Dryden Breakdown of academic impact, for papers by Peggy Kirstetter
Rankless by CCL
2026